Literature DB >> 20482396

Dry eye disease as an inflammatory disorder.

Margarita Calonge1, Amalia Enríquez-de-Salamanca, Yolanda Diebold, María J González-García, Roberto Reinoso, José M Herreras, Alfredo Corell.   

Abstract

PURPOSE: Dry eye disease (DED) is a prevalent inflammatory disorder of the lacrimal functional unit of multifactorial origin leading to chronic ocular surface disease, impaired quality of vision, and a wide range of complications, eventually causing a reduction in quality of life. It still is a frustrating disease because of the present scarcity of therapies that can reverse, or at least stop, its progression.
METHODS: A comprehensive literature survey of English-written scientific publications on the role of inflammation in DED.
RESULTS: New investigations have demonstrated that a chronic inflammatory response plays a key role in the pathogenesis of human DED. Additionally, correlations between inflammatory molecules and clinical data suggest that inflammation can be responsible for some of the clinical symptoms and signs.
CONCLUSIONS: Research efforts to clarify its pathophysiology are leading to a better understanding of DED, demonstrating that inflammation, in addition to many other factors, plays a relevant role.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482396     DOI: 10.3109/09273941003721926

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  41 in total

Review 1.  The core mechanism of dry eye disease is inflammation.

Authors:  Yi Wei; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2014-07       Impact factor: 2.018

2.  Evaluation of patients with dry eye disease for conjunctival Chlamydia trachomatis and Ureaplasma urealyticum.

Authors:  Maha Mohssen Abdelfattah; Rania Abdelmonem Khattab; Magda H Mahran; Ebrahim S Elborgy
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

3.  Evidence for TRPA1 involvement in central neural mechanisms in a rat model of dry eye.

Authors:  A Katagiri; R Thompson; M Rahman; K Okamoto; D A Bereiter
Journal:  Neuroscience       Date:  2015-01-30       Impact factor: 3.590

4.  Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease.

Authors:  M Guzmán; I Keitelman; F Sabbione; A S Trevani; M N Giordano; J G Galletti
Journal:  Clin Exp Immunol       Date:  2016-02-15       Impact factor: 4.330

5.  Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye.

Authors:  Min Zhong; Thomas R Gadek; Minna Bui; Wang Shen; John Burnier; Kenneth J Barr; Emily J Hanan; Johan D Oslob; Chul H Yu; Jiang Zhu; Michelle R Arkin; Marc J Evanchik; W Mike Flanagan; Ute Hoch; Jennifer Hyde; Saileta Prabhu; Jeffrey A Silverman; Jasmin Wright
Journal:  ACS Med Chem Lett       Date:  2012-01-31       Impact factor: 4.345

Review 6.  Non-invasive objective and contemporary methods for measuring ocular surface inflammation in soft contact lens wearers - A review.

Authors:  Cecilia Chao; Kathryn Richdale; Isabelle Jalbert; Kim Doung; Moneisha Gokhale
Journal:  Cont Lens Anterior Eye       Date:  2017-06-09       Impact factor: 3.077

7.  Alcohol consumption and dry eye syndrome: a Meta-analysis.

Authors:  Yong-Sheng You; Nai-Bin Qu; Xiao-Ning Yu
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

Review 8.  Dry eye disease and microbial keratitis: is there a connection?

Authors:  Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

Review 9.  Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?

Authors:  Akanksha Gupta; Sonika Bhatnagar
Journal:  OMICS       Date:  2015-12

10.  Role of NFAT5 in inflammatory disorders associated with osmotic stress.

Authors:  Wolfgang Neuhofer
Journal:  Curr Genomics       Date:  2010-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.